Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th September, 202218-10-2022
Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th September, 2022Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting results for 28th Annual General Meeting of the Company.Parmax Pharma Ltd - 540359 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- YASH VORADesignation :- Company Secretary and Compliance OfficerParmax Pharma Ltd - 540359 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting results and Consolidated Scrutinizer''s Report for 28th Annual General Meeting of the Company.Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 28th Annual General Meeting of the companyParmax Pharma Ltd - 540359 - Reg. 34 (1) Annual Report.
Corrigendum To The Annual Report For The Financial Year 2021-22.Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper Advertisement for Notice of Annual General Meeting, E-voting information and Book Closure.Parmax Pharma Ltd - 540359 - Reg. 34 (1) Annual Report.
Submission of Annual Report for Financial year 2021-22 along with Notice of 28th Annual General Meeting to be held on 30th September, 2022.